Clinical Trial

Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD

Name: Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD — clinical trial record (NCT07491523)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated March 24, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Summary

Patients with ssc-ild receiving double immunosuppression with or without anti fibrotic tratment

Trial Details

NCT Number	NCT07491523
Lead Sponsor	University of Patras
Conditions	SSc-Systemic Sclerosis
Enrollment	35 participants
Start Date	2025-06-01
Primary Completion	2026-07 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-24